Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis

Levosimendan and dobutamine are extensively used to treat sepsis-associated cardiovascular failure in ICU. Nevertheless, the role and mechanism of levosimendan in patients with sepsis-induced cardiomyopathy remains unclear. Moreover, previous studies on whether levosimendan is superior to dobutamine...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dong-Hua, Ning, Yi-Le, Lei, Yan-Yan, Chen, Jing, Liu, Yan-Yan, Lin, Xin-Feng, Yang, Zhong-Qi, Xian, Shao-Xiang, Chen, Wei-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514594/
https://www.ncbi.nlm.nih.gov/pubmed/34645892
http://dx.doi.org/10.1038/s41598-021-99716-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514594/
https://www.ncbi.nlm.nih.gov/pubmed/34645892
http://dx.doi.org/10.1038/s41598-021-99716-9

Ejemplares similares